Scinai Immunotherapeutics (SCNI) Research & Development (2014 - 2026)
Scinai Immunotherapeutics (SCNI) reported Research & Development of -$628000.0 for Q1 2026, up 51.51% on a YoY basis from -$414505.6 in Q1 2025, and down 1182.76% sequentially from $58000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Research & Development (2014 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 13 years of Research & Development data on file, last reported at -$628000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 51.51% year-over-year to -$628000.0; the trailing twelve-month figure through Mar 2026 stood at -$528000.0 (up 90.77% YoY), and the FY2025 full-year result was -$2.4 million, down 142.82% from the prior year.
- Research & Development slipped to -$628000.0 in Q1 2026, from $58000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.0 million in Q1 2023 to a low of -$4.4 million in Q2 2024.
- A 5-year average of $416800.0 and a median of $1.2 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 141.83% in 2022 and sank 399.59% in 2024, its largest moves.
- Tracing SCNI's Research & Development over 5 years: stood at $1.4 million in 2022, then tumbled by 56.28% to $627000.0 in 2023, then surged by 113.24% to $1.3 million in 2024, then slumped by 95.66% to $58000.0 in 2025, then tumbled by 1182.76% to -$628000.0 in 2026.
- Business Quant data shows SCNI's Research & Development at -$628000.0 in Q1 2026, $58000.0 in Q2 2025, and -$1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -628,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | -1.30 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -4.36 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 627,000.00 |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | -3.43 Mn |
| Sep 30, 2021 | 2.02 Mn |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 825,000.00 |
| Dec 31, 2020 | 11.95 Mn |